1. Home
  2. CTKB vs KALV Comparison

CTKB vs KALV Comparison

Compare CTKB & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • KALV
  • Stock Information
  • Founded
  • CTKB 1990
  • KALV N/A
  • Country
  • CTKB United States
  • KALV United States
  • Employees
  • CTKB N/A
  • KALV N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTKB Health Care
  • KALV Health Care
  • Exchange
  • CTKB Nasdaq
  • KALV Nasdaq
  • Market Cap
  • CTKB 718.8M
  • KALV 651.3M
  • IPO Year
  • CTKB 2021
  • KALV N/A
  • Fundamental
  • Price
  • CTKB $2.83
  • KALV $12.92
  • Analyst Decision
  • CTKB Hold
  • KALV Strong Buy
  • Analyst Count
  • CTKB 4
  • KALV 8
  • Target Price
  • CTKB $6.00
  • KALV $24.83
  • AVG Volume (30 Days)
  • CTKB 1.1M
  • KALV 498.7K
  • Earning Date
  • CTKB 05-08-2025
  • KALV 07-10-2025
  • Dividend Yield
  • CTKB N/A
  • KALV N/A
  • EPS Growth
  • CTKB N/A
  • KALV N/A
  • EPS
  • CTKB N/A
  • KALV N/A
  • Revenue
  • CTKB $197,050,000.00
  • KALV N/A
  • Revenue This Year
  • CTKB $3.25
  • KALV N/A
  • Revenue Next Year
  • CTKB $8.58
  • KALV N/A
  • P/E Ratio
  • CTKB N/A
  • KALV N/A
  • Revenue Growth
  • CTKB N/A
  • KALV N/A
  • 52 Week Low
  • CTKB $2.37
  • KALV $7.30
  • 52 Week High
  • CTKB $7.63
  • KALV $15.50
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 43.14
  • KALV 60.56
  • Support Level
  • CTKB $2.37
  • KALV $11.11
  • Resistance Level
  • CTKB $2.61
  • KALV $11.93
  • Average True Range (ATR)
  • CTKB 0.18
  • KALV 0.60
  • MACD
  • CTKB 0.04
  • KALV 0.05
  • Stochastic Oscillator
  • CTKB 63.45
  • KALV 80.09

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

Share on Social Networks: